Skip to content
MedsAcross

Medicine

Potassium chloride 600 mg extended-release tablet

Available on requestPrescription onlyUS FDAGeneric name

Potassium chloride 600 mg extended-release tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Potassium chloride
Brand
Sold under the generic name
Strength
600 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 120 blister pack and 33 more
Manufacturers
Granules IndiaIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaStrides PharmaIndiaBryant Ranch PrepackUpsher-Smith LaboratoriesEpic PharmaRising Pharma HoldingsSlate Run Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A12BA01 Potassium chloride
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 April 1986
Identifiers
RxCUI 312529, 628953DailyMed set ID a230185f-5493-487d-892a-5219869b4e47, 0224e5b3-3c49-4e6e-aa78-1abcc6969246, d43beabe-b801-4319-ad36-9a80856b94bd +7NDC 24979-229, 64380-860, 65862-986 +7Application ANDA218979, ANDA210733, ANDA210921 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated, extended release in 1 bottle65862-986-01Aurobindo PharmaIndia19 December 2018
500 tablet, film coated, extended release in 1 bottle65862-986-05Aurobindo PharmaIndia19 December 2018
120 blister pack in 1 carton / 6 tablet, film coated, extended release in 1 blister pack65862-986-12Aurobindo PharmaIndia19 December 2018
80 blister pack in 1 carton / 4 tablet, film coated, extended release in 1 blister pack65862-986-80Aurobindo PharmaIndia19 December 2018
100 tablet, extended release in 1 bottle70010-021-01Granules IndiaIndia22 October 2020
500 tablet, extended release in 1 bottle70010-021-05Granules IndiaIndia22 October 2020
1000 tablet, extended release in 1 bottle70010-021-10Granules IndiaIndia4 May 2021
3 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack70010-021-61Granules IndiaIndia3 January 2022
10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack70010-021-62Granules IndiaIndia3 January 2022
100 tablet, film coated, extended release in 1 bottle33342-417-11Macleods PharmaceuticalsIndia8 September 2024
10 blister pack in 1 carton / 10 tablet, film coated, extended release in 1 blister pack33342-417-12Macleods PharmaceuticalsIndia8 September 2024
500 tablet, film coated, extended release in 1 bottle33342-417-15Macleods PharmaceuticalsIndia8 September 2024
10 blister pack in 1 carton / 7 tablet, film coated, extended release in 1 blister pack33342-417-34Macleods PharmaceuticalsIndia8 September 2024
100 tablet, extended release in 1 bottle64380-860-06Strides PharmaIndia19 November 2018
500 tablet, extended release in 1 bottle64380-860-07Strides PharmaIndia27 November 2018
1000 tablet, extended release in 1 bottle64380-860-08Strides PharmaIndia27 November 2018
1000 tablet, film coated, extended release in 1 bottle0832-5322-10Upsher-Smith Laboratories21 June 2019
100 tablet, film coated, extended release in 1 bottle0832-5322-11Upsher-Smith Laboratories21 June 2019
80000 tablet, extended release in 1 drum24979-229-00Upsher-Smith Laboratories1 June 2025
100 tablet, extended release in 1 bottle24979-229-01Upsher-Smith Laboratories28 October 2024
1000 tablet, extended release in 1 bottle24979-229-03Upsher-Smith Laboratories28 October 2024
100 tablet, film coated, extended release in 1 bottle42806-422-01Epic Pharma7 August 2023
500 tablet, film coated, extended release in 1 bottle42806-422-05Epic Pharma7 August 2023
1000 tablet, film coated, extended release in 1 bottle42806-422-10Epic Pharma7 August 2023
100 tablet, extended release in 1 bottle16571-842-01Rising Pharma Holdings13 February 2025
1000 tablet, extended release in 1 bottle16571-842-10Rising Pharma Holdings18 September 2025
500 tablet, extended release in 1 bottle16571-842-50Rising Pharma Holdings13 February 2025
100 tablet, film coated, extended release in 1 bottle70436-001-01Slate Run Pharmaceuticals15 November 2018
500 tablet, film coated, extended release in 1 bottle70436-001-02Slate Run Pharmaceuticals15 November 2018
1000 tablet, film coated, extended release in 1 bottle70436-001-03Slate Run Pharmaceuticals15 November 2018
30 tablet, film coated, extended release in 1 bottle63629-2620-1Bryant Ranch Prepack6 February 2024
60 tablet, film coated, extended release in 1 bottle63629-2620-2Bryant Ranch Prepack6 February 2024
90 tablet, film coated, extended release in 1 bottle63629-2620-3Bryant Ranch Prepack6 February 2024
180 tablet, film coated, extended release in 1 bottle63629-2620-4Bryant Ranch Prepack6 February 2024
100 tablet, film coated, extended release in 1 bottle63629-2620-5Bryant Ranch Prepack6 February 2024
20 tablet, film coated, extended release in 1 bottle63629-2620-6Bryant Ranch Prepack6 February 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 April 1975Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Potassium chloride 600 mg extended-release tablet.

Compare all 2

Other strengths and forms of Potassium chloride

Clinical summary

Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Potassium chloride

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Potassium chloride 600 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.